Shionogi Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHIONOGI INC, and what generic alternatives to SHIONOGI INC drugs are available?
SHIONOGI INC has five approved drugs.
There are four US patents protecting SHIONOGI INC drugs.
There are seventy-two patent family members on SHIONOGI INC drugs in thirty-eight countries and thirty-three supplementary protection certificates in sixteen countries.
Summary for Shionogi Inc
| International Patents: | 72 |
| US Patents: | 4 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Shionogi Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-002 | Oct 5, 2010 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-004 | Sep 9, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-001 | Oct 12, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | 9,949,982 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Shionogi Inc | ULESFIA | benzyl alcohol | LOTION;TOPICAL | 022129-001 | Apr 9, 2009 | DISCN | Yes | No | 7,294,342 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Shionogi Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-002 | Oct 5, 2010 | 5,317,016 | ⤷ Try a Trial |
| Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-004 | Sep 9, 1993 | 4,631,286 | ⤷ Try a Trial |
| Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-002 | Sep 9, 1993 | 4,631,286 | ⤷ Try a Trial |
| Shionogi Inc | ULESFIA | benzyl alcohol | LOTION;TOPICAL | 022129-001 | Apr 9, 2009 | 6,793,931 | ⤷ Try a Trial |
| Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-002 | Sep 9, 1993 | 4,816,456 | ⤷ Try a Trial |
| Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-001 | Sep 9, 1993 | 4,631,286 | ⤷ Try a Trial |
| Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-004 | Sep 9, 1993 | 4,816,456 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SHIONOGI INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Lotion | 5% | ➤ Subscribe | 2016-04-11 |
| ➤ Subscribe | Injection | 250 mg/vial and 500 mg/vial | ➤ Subscribe | 2011-10-11 |
International Patents for Shionogi Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20170043663 | ⤷ Try a Trial |
| Hungary | E056038 | ⤷ Try a Trial |
| Taiwan | I535727 | ⤷ Try a Trial |
| European Patent Office | 3190115 | ⤷ Try a Trial |
| European Patent Office | 2960244 | ⤷ Try a Trial |
| South Africa | 201102024 | ⤷ Try a Trial |
| Brazil | PI0921701 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shionogi Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2960244 | 132020000000136 | Italy | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL, OPZIONALMENTE NELLA FORMA DI UN SALE FARMACEUTICAMENTE ACCETTABILE O SOLVATO(FETCROJA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1434, 20200424 |
| 2960244 | LUC00179 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL, EVENTUELLEMENT SOUS LA FORME D'UN SEL OU D'UN SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE; AUTHORISATION NUMBER AND DATE: EU/1/20/1434 20200424 |
| 1307486 | SPC/GB12/030 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: CYCLO((4R)-4-(2-AMINOETHYLCARBAMOYLOXY)-L-PROLYL-L-PHENYLGLYCYL-D-TRYPTOPHYL-L-LYSYL-4-O-BENZYL-L-TYROSYL-L-PHENYLALANYL-)), PASIREOTIDE, OR SALTS THEREOF; REGISTERED: UK EU/1/12/753/001-012 20120424 |
| 0528678 | C00528678/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: DORIPENEMUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 58667 19.10.2009 |
| 2960244 | SPC/GB20/053 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE; REGISTERED: UK EU/1/20/1434 (NI) 20200424; UK PLGB 50999/0009 20200424 |
| 0528678 | SPC/GB09/006 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: DORIPENEM; REGISTERED: UK EU/1/08/467/001 20080725 |
| 2960244 | 2090041-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROKOL; REG. NO/DATE: EU/1/20/1434 20200424 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
